Trial Profile
The Multicenter Atorvastatin Plaque Stabilization (MAPS) Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Colestyramine; Sitosterol
- Indications Atherosclerosis; Hypercholesterolaemia
- Focus Pharmacodynamics
- Acronyms MAPS
- 22 Apr 2010 Results have been publsihed (Stroke: 22 Apr 2010.)
- 28 Jan 2010 New trial record